AcronGenomics Inc. Successfully Demonstrates Creatinine Measurement in Urine on Standalone Demonstrator Device

GENEVA--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM) and its research partner Molecular Vision Ltd. are pleased to announce the successful implementation of a fully functional, portable medical diagnostic demonstrator of their Lab-on-a-Chip technology. The demonstrator employs patented, organic semiconductor technology in a high sensitivity, handheld, medical diagnostic device. The successful presentation of the demonstrator device took place at Imperial College in London, UK, on October 11th 2007.

MORE ON THIS TOPIC